Prevalence and economic evaluation of acute uncomplicated cystitis in women from Japan: a retrospective cohort study
Healthcare providers should consider the cost implications for patients with antibiotic TF or a history of AUC recurrence when selecting antibiotics for empiric treatment in Japan.
Authors
- Madison T Preib (ORCID: https://orcid.org/0000-0001-6704-5068)
- Shinyoung Ju (ORCID: https://orcid.org/0000-0003-1011-4434)
- Maia R. Emden
- Naomi Sacks (ORCID: https://orcid.org/0000-0003-0038-4385)
- Fanny S Mitrani-Gold (ORCID: https://orcid.org/0000-0001-8829-7088)
- Yoshiaki Kawano (ORCID: https://orcid.org/0000-0002-2305-1711)
- Shinya Kawamatsu (ORCID: https://orcid.org/0000-0003-2207-0133)
- Ashish V. Joshi (ORCID: https://orcid.org/0000-0002-7089-1545)
Institutions
- Health Outcomes Solutions (United States) (US)
- GlaxoSmithKline (Japan) (JP)
- Precision for Medicine (United States) (US)
- BioStrategies (United States) (US)
- Diagnostics for the Real World (United Kingdom) (GB)
Publication Details
- Journal
- JAC-Antimicrobial Resistance
- Published
- 2025-09-03
- DOI
- https://doi.org/10.1093/jacamr/dlaf178
- Primary Topic
- Urinary Tract Infections Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00